CALDOB
CALDOB
CALDOB
Mechanism of Action
• Decreases platelet aggregation by inhibiting platelet aggregation factor (PAF).
This prevents formation of thrombus.
• Decreases hyper-viscosity of blood by inhibiting lipid peroxidation of
erythrocytes. This increases RBC membrane flexibility and helps in free flow
of blood, enhances release of tissue plasminogen activator (TPA), thus
increases fibrinolytic activity.
• Strengthens blood vessels, improves integrity of blood vessels.
• Reduces hyper-permeability by synthesizing nitric oxide which helps to relax
blood vessels, reduces oedema, heaviness and pain in legs.
• Also inhibits synthesis of prostaglandins.
TREATMENT IN ED
1. Phosphodiesterase enzyme inhibitors (pde-5 inhibitors). Exp: sildnafil,
tadalafil.
2. Nitric oxide donors. Exp: calcium dobesilate (CALDOB).
TESTIMONIALS
• Phsophodiestrases-5 (PDE-5) inhibitors are less effective in the treatment of
E.D. in diabetic men.
• Unlike sildenafil, CALDOB fully reverse diabetes induced endothelium
dysfunction in penile resistance arteries.
DOSAGE: one cap BID for 4 to 8 weeks or till the satisfactory result.